Gastrointestinal stromal tumor | Tumor

CURE’s gastrointestinal stromal tumor page features the latest cancer news and updates on gastrointestinal stromal tumors Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in the gastrointestinal stromal tumor.

RECKGIST Score May Predict Recurrence in Neurofibromatosis Type 1 GISTs

March 12th 2025, 1:00pm

Article

RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according to study findings.

Pimitespib Associated With Stable Disease for Some Patients With GIST

March 11th 2025, 1:00pm

Article

Treatment with pimitespib was associated with stable disease in two-thirds of patients with advanced gastrointestinal stromal tumors.

Gleevec Response in GIST May Be Linked to Mutational Profile

March 10th 2025, 1:00pm

Article

Gleevec response in GIST varies by mutational profile, with KIT-exon-11 mutation linked to better outcomes, emphasizing mutation testing for treatment decisions.

GI Bleeding Significantly Impacts GIST Treatment Outcomes

February 12th 2025, 8:00pm

Article

The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.

Neoadjuvant TKI Prior to Surgery Has Surgical Benefit in Non-Metastatic GIST

February 7th 2025, 2:00pm

Article

Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less invasive or complex surgeries.

Bezuclastinib Plus Sutent May Be Safe and Effective in GIST

January 24th 2025, 6:30pm

Article

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

Surgery May Extend Survival For Patients with GIST and Liver Metastases

January 16th 2025, 4:00pm

Article

For patients with gastrointestinal stromal tumors with liver metastases, treatment with surgery and chemotherapy has been found to have survival benefits.

Machine Learning Predicts Gleevec Nonadherence in Patients With GIST

January 15th 2025, 4:00pm

Article

Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others in patients with GIST.

Laparoscopic Wedge and Endoscopic Resection Are Safe, Feasible in Gastric GISTs

January 9th 2025, 8:00pm

Article

Both laparoscopic wedge and endoscopic resection are safe and feasible treatment approaches for patients with gastric gastrointestinal stromal tumors.

Gleevec Interruption in GIST Associated with Resistance, Recurrence, Death

October 2nd 2024, 7:00pm

Article

Researchers are advising against the interruption of treatment with Gleevec among patients with advanced gastrointestinal stromal tumors.